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Abstract
This systematic review addresses the pathophysiol-
ogy, diagnostic evaluation, and treatment of several 
chronic pain syndromes affecting the pelvic organs: 
chronic proctalgia, coccygodynia, pudendal neuralgia, 
and chronic pelvic pain. Chronic or recurrent pain in 
the anal canal, rectum, or other pelvic organs occurs 
in 7% to 24% of the population and is associated with 
impaired quality of life and high health care costs. 
However, these pain syndromes are poorly understood, 
with little research evidence available to guide their 
diagnosis and treatment. This situation appears to 
be changing: A recently published large randomized, 
controlled trial by our group comparing biofeedback, 
electrogalvanic stimulation, and massage for the treat-
ment of chronic proctalgia has shown success rates of 
85% for biofeedback when patients are selected based 
on physical examination evidence of tenderness in re-
sponse to traction on the levator ani muscle-a physical 
sign suggestive of striated muscle tension. Excessive 
tension (spasm) in the striated muscles of the pelvic 
floor appears to be common to most of the pelvic pain 
syndromes. This suggests the possibility that similar 
approaches to diagnostic assessment and treatment 
may improve outcomes in other pelvic pain disorders.
© 2011 Baishideng. All rights reserved.
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INTRODUCTION
Chronic or frequently recurring pain in the anal canal, 
rectum, or pelvis is a prevalent symptom that affects an 
estimated 6.6% of  the population[1]. Although only 1/3 
of  people with such pains consult physicians, they nev-
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ertheless report significant impairment in quality of  life, 
work absenteeism, and psychological distress. However, 
despite its prevalence and impact, relatively little research 
has been published which addresses its epidemiology, 
pathophysiology, and treatment; and pelvic and rectal 
pain is widely considered frustrating to diagnose and 
treat. This may soon change: Our group recently report-
ed a randomized controlled trial[2] in which we compared 
different approaches to treating chronic proctalgia and 
showed that the results were excellent 85% success rate-
if  the patients were appropriately screened. This study 
also provided new insights into the pathophysiology of  
chronic proctalgia and stimulated renewed interest in 
anorectal pain syndromes. The aims of  this review are to 
critically assess what is known about the diagnosis and 
treatment of  the most common forms of  anorectal and 
pelvic pain, namely chronic proctalgia, chronic pelvic 
pain, coccygodynia, and pudendal neuralgia. This review 
is meant to help Gastroenterologists and Colorectal Sur-
geons when dealing with complex consultation on pelvic 
pain syndromes. It is mostly focused on chronic proctal-
gia and issues of  differential diagnosis with other pelvic 
pain syndromes.
One of  the challenges in caring for patients with 
anorectal and pelvic pain is that a number of  inflamma-
tory and structural etiologies must be considered. The 
organic diseases that are most commonly involved in 
chronic anorectal and pelvic pain are cryptitis, fissure, 
abscess, hemorrhoids, solitary rectal ulcer, inflammatory 
bowel disease, and rectal ischemia[3]. One should also 
consider chronic prostatitis and pelvic endometriosis as 
potential contributors to chronic pelvic pain[3]. Although 
the differential diagnosis is large and unfortunately 
poorly standardized, our experience[2] suggests that no 
organic disease explanation will be found in approxi-
mately 85% of  patients presenting to gastroenterologists 
with chronic anorectal or pelvic pain. We screened 227 
patients referred for unremitting, chronic rectal pain 
with a diagnostic evaluation that included digital rectal 
examination, colonoscopy, pelvic ultrasound and surgical 
consultation in all patients, plus gynecology and urol-
ogy referrals in selected cases[2]. This extensive work-up 
identified only 33 patients (15%) with a probable organic 
disease accounting for their symptoms. Thus, for most 
patients with chronic anorectal or pelvic pain, the origin 
of  the pain is uncertain and the relevant pathophysi-
ological mechanisms are unclear. These are commonly 
defined as “functional” chronic anorectal and pelvic pain 
syndromes since no structural and anatomical disease 
was found. These functional pain syndromes constitute 
the main subject of  this review.
CHRONIC PROCTALGIA
Chronic proctalgia is a general term for chronic or re-
curring pain in the anal canal or rectum[3]. Other names 
considered synonymous with chronic proctalgia are 
levator ani syndrome, puborectalis syndrome, chronic 
idiopathic perineal pain, pyriformis syndrome, and pelvic 
tension myalgia. Thiele, one of  the first researchers to 
investigate this pain syndrome, called it coccygodynia, 
although he acknowledged that the pain was not in the 
coccyx[4]. To provide greater consistency in the diagnosis 
and labeling of  anorectal pain syndromes, the Rome Ⅲ 
criteria[3] define chronic proctalgia as chronic or recur-
rent rectal pain or aching lasting at least 20 min, in the 
absence of  structural or systemic disease explanations 
for these symptoms[3]. Pain duration of  at least 20 min is 
a key feature since shorter episodes of  pain are sugges-
tive of  proctalgia fugax, which is defined as a sudden, se-
vere pain in the anorectal region lasting less than 20 min 
and then disappearing completely[3]. Proctalgia fugax 
may recur, but episodes are rare. Proctalgia fugax is be-
lieved to have a different etiology to chronic proctalgia, 
although there is no consensus on what causes it. Its 
consideration is beyond the scope of  this review, which 
is intended to deal with chronic unremitting diseases. 
Chronic proctalgia is further divided by the Rome Ⅲ 
criteria into two subtypes-levator ani syndrome (LAS) 
and unspecified functional anorectal pain-based on the 
presence or absence of  a sensation of  tenderness when 
the levator muscle is palpated during digital rectal exami-
nation. This classification updates the previous Rome 
Ⅱ classification in which LAS was designated as “highly 
likely” if  traction on the pelvic floor produced a report 
of  tenderness and only “possible LAS” if  no tender-
ness was elicited[5]. Subgrouping patients with chronic 
proctalgia is consistent with clinical experience of  dif-
ferent response to treatment, but distinct epidemiology 
and pathophysiology data are lacking[5]. Therefore, data 
provided mostly refer to chronic proctalgia patients as a 
whole.
Pathophysiology
Chronic tension or spasm of  the striated muscles of  the 
pelvic floor is commonly assumed to be the pathophysi-
ological basis for chronic proctalgia[3,5-7], although there is 
no definitive evidence for this hypothesis. Inflammation 
of  the levator or arcus tendon of  the levator ani muscle 
has also been suggested as a cause of  chronic proctalgia, 
since tenderness on palpation is most commonly found 
on the left side where the muscle inserts into the pubic 
ramus of  the pelvis. However, contrary to this tendinitis 
hypothesis, local steroid injection has not been shown 
to be an effective treatment for chronic proctalgia[8]. In 
retrospective studies, many patients reported prior pel-
vic surgery, anal surgery and even spinal surgery as sig-
nificant in the development of  their pain syndrome[6,9]. 
Childbirth can be another precipitating factor[9]. In ad-
dition, high rates of  anxiety disorders, depression, and 
stress are frequently reported in chronic proctalgia, and 
may act as significant precipitating factors in some pa-
tients[6,10].
Except for the exclusion of  organic diseases, tests of  
anorectal physiology and imaging studies were tradition-
ally considered to be of  little diagnostic or prognostic 
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value[11,12]. Increased anal canal resting pressures tested 
by anorectal manometry were sometimes reported, 
but results were inconsistent. Grimaud and coworkers 
reported that LAS was associated with anal sphinc-
ter hypertonia and disordered defecation on dynamic 
proctography in a study of  12 patients, but this was not 
confirmed in a larger prospective study of  60 patients by 
Ger and coworkers[11,13] . Ger et al[11] reported that LAS 
was associated with paradoxical contraction of  the pelvic 
floor muscles on straining as evidenced by anal electro-
myography or defecography. However, all these stud-
ies were potentially biased by small size, mixed patient 
population, and poor patient selection[3,5]. In addition, a 
number of  structural disorders (descending perineum, 
rectocele, mucosal prolapse and pelvic floor dyssyenrgia) 
have been reported in small studies[6,11-13]. 
In a recent study, Hompes et al[14] reported on 59 patients 
referred to a Pelvic Floor Clinic for chronic functional 
anorectal pain who were tested by means of  defecating 
proctography, anorectal manometry, anal ultrasound, and 
in selected cases, rectal examination under anesthesia. 
The same diagnostic protocol was applied to 543 rectal 
prolapse patients complaining of  obstructed defecation 
and to a control group of  patients with fecal inconti-
nence. In the control group with fecal incontinence, pain 
was reported in 50% of  patients but was a non-dominant 
symptom. Anorectal manometry failed to show any dif-
ference among groups. Rectal morphology examinations 
demonstrated high grade internal rectal prolapse in 59% 
of  pain patients, which was often associated with symp-
toms of  obstructed defecation. The authors concluded 
that rectal prolapse commonly underlies chronic proct-
algia, particularly when obstructed defecation is present. 
However, the severity of  prolapse did not correlate with 
pain intensity, leaving pain pathophysiology unclear[14]. In 
addition, chronic idiopathic rectal pain is sometimes re-
ported as a complication of  corrective surgery for rectal 
prolapse[14].
 An innovative pathophysiology explanation for 
chronic proctalgia was recently reported by our group in 
a large, prospective, randomized controlled trial compar-
ing biofeedback, electrogalvanic stimulation (EGS), and 
digital massage of  the levator muscles for the treatment 
of  chronic proctalgia. In this study, 157 patients with 
chronic proctalgia (confirmed by Rome Ⅱ criteria) were 
studied by anorectal manometry and a balloon evacua-
tion test at baseline and again after 3 mo of  treatment[2]. 
Based on a priori exclusion criteria, patients reporting 
symptoms consistent with either irritable bowel syn-
drome or functional constipation were not enrolled in 
the study. In patients reporting tenderness on palpation 
of  the levator muscles (Rome Ⅱ: highly likely LAS, 
Rome Ⅲ: LAS), physiologic features of  dyssynergic def-
ecation (i.e., paradoxical contraction or failure to relax 
the pelvic floor on straining) were seen in approximately 
85% of  subjects in the absence of  symptoms of  consti-
pation. Conversely, in patients who denied tenderness 
when the levators were palpated during digital rectal 
examination, inability to relax pelvic floor muscles when 
straining was an uncommon finding (19%). Dyssynergic 
defecation was a strong predictor of  successful treat-
ment outcome. These observations led us to conclude 
that the physiologic mechanisms responsible for LAS 
and dyssynergic defecation are similar[2]. 
This study also showed that the inability to relax 
pelvic floor muscles when straining to defecate may oc-
cur without symptoms of  constipation, even though 
it is commonly assumed that dyssynergic defecation 
invariably results in obstructed defecation. Factors that 
interact with pelvic floor physiology to determine which 
symptoms develop-either pain or constipation-are left 
unanswered by our study and deserve further investiga-
tions. Also, we were not able to provide a physiological 
explanation for unspecified functional anorectal pain (i.e., 
anorectal pain without tenderness on digital palpation), 
which may represent a heterogeneous group of  patients. 
Our study suggests, however, that adding a simple bal-
loon evacuation test with a disposable Foley catheter to 
the diagnostic work up of  chronic proctalgia patients en-
ables one to select subjects that are more likely to benefit 
from pelvic floor rehabilitation.  
Clinical presentation
Chronic proctalgia is often described by patients as a 
dull ache or pressure sensation in the rectum that is ex-
acerbated by prolonged sitting and relieved by standing 
or lying down[3,5]. This pain rarely occurs at night; rather, 
it usually begins in the morning and increases in sever-
ity throughout the day. The pain may be precipitated by 
long-distance car travelling, stress, sexual intercourse 
and defecation[6,7]. During digital rectal examination, the 
examining finger is moved from the coccyx posteriorly 
to the symphysis pubis anteriorly[5,7]. For unexplained rea-
sons, tenderness is often non-symmetric, being greater on 
the left side than on the right[5]. When performing digital 
rectal examination, the examiner should pause after in-
serting their finger into the rectum before applying trac-
tion on the levator muscles to avoid false positive results. 
In our experience, repeating the posterior traction on the 
levator muscle on the same exam is also useful to check 
for reproducibility and to avoid false positive results. 
Diagnostic assessment
Although our recent study provides new insights into the 
pathophysiology of  chronic proctalgia, these observa-
tions require validation by other laboratories before they 
can be incorporated as diagnostic criteria. The diagnosis 
of  chronic proctalgia still relies on (1) clinical symptoms 
of  recurring or chronic pain or aching in the anal canal 
or rectum with episodes lasting 20 min or longer[3], and 
(2) exclusion of  alternative disease explanations for 
these symptoms by multiple diagnostic tests and con-
sultations by other specialists. In addition, digital rectal 
examination should be performed to ascertain whether 
the patient reports tenderness when traction is applied 
to the levator ani muscles because this diagnostic sign 
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is a strong predictor of  whether the patient is likely to 
benefit from treatments directed at relaxing pelvic floor 
muscles. 
Treatment
No single treatment has been reported to be consistently 
effective in chronic proctalgia[3,7], and management can 
be a frustrating endeavor for both patients and physi-
cians[11]. The first-line treatment most commonly pro-
vided is reassurance that the pain is of  benign origin and 
is not suggestive of  malignancy[7,9]. No data are available 
on the impact of  reassurance, but education and coun-
seling are often incorporated as a component of  treat-
ment. 
Digital massage of  the puborectalis sling, intended 
to relax tense muscles, was one of  the first treatments 
proposed for chronic proctalgia[9]. Massage of  the pu-
borectalis muscle should be performed in a firm manner 
with the affected side massaged up to 50 times, depend-
ing on the patient’s tolerance. Some claim that if  the 
massage is not uncomfortable to the patient while being 
performed, it may not be effective[9]. Massage of  the le-
vator ani muscle is rarely performed as the sole therapy, 
with the most common adjunctive treatments being hot 
sitz baths or a short-term course of  oral Diazepam, both 
of  which are assumed to have myorelaxant properties. 
Earlier open-label studies suggested that digital massage 
combined with hot sitz baths and/or Diazepam were 
effective for relieving pain in 68% of  316 chronic proct-
algia patients[15]. However, benefits seemed to fade away 
during long-term follow-up, and the addictive potential 
of  Diazepam discourages long-term treatment[7].
Electrogalvanic stimulation, traditionally used by 
physiatrists to treat muscle spasticity[9], has also been 
advocated for the treatment of  LAS when conserva-
tive therapy is ineffective. A low frequency oscillating 
current applied to the pelvic floor muscles through an 
anal probe, induces fasciculation and prolonged fa-
tigue, which breaks the spastic cycle and may produce 
sustained symptom relief. Low frequency current has 
no thermal effect. No side effects have ever been re-
ported other than mild worsening of  pain on the first 
days of  treatment. Sohn and coworkers were the first 
to test EGS in an open study of  80 chronic proctalgia 
patients[16]. They recommended a pulse frequency of  80 
cycles per second with the voltage being gradually in-
creased from zero to the point of  discomfort (250-300 
Volts according to patient’s tolerance). Recommended 
treatment duration is one hour per day for 3 sessions in 
a ten-day period. In the Sohn study[16], 91% of  patients 
reported good to excellent pain relief  from EGS in the 
short-term, but no long-term follow-up was reported. 
This high percentage of  success was never replicated by 
subsequent open label studies, although approximately 
two-thirds of  patients did report short-term pain relief. 
Treatment protocols varied widely in terms of  number 
and duration of  sessions. Authors claimed that non-
responders showed features of  psychology disturbances, 
but no evidence was provided on the issue. However, 
three additional studies that investigated the long-term 
benefits of  EGS treatment in chronic proctalgia found 
that only 25%-38% of  patients reported persistent pain 
improvement[17-19]. 
Biofeedback treatment of  LAS was first described 
in 1991 by Grimaud and coworkers[13]. They treated 12 
patients with biofeedback techniques focused on vol-
untary relaxation of  external anal sphincter tone. Pain 
disappeared in all patients after a mean of  eight sessions. 
Subsequent studies using biofeedback were not able to 
replicate these results, with success rates varying from 
35% to 87.5%[6,11,19]. All studies were small, none was 
controlled, and treatment modalities varied. 
Botulinum Toxin A (BoTox A) was tested in a ran-
domized controlled trial run in 12 patients, and no dif-
ferences in rectal pain were observed between patients 
injected with active BoTox versus those injected with 
saline[20]. The average amount of  time required to def-
ecate a rectal balloon was actually increased after BoTox 
injection. The tendinitis (inflammation) hypothesis for 
chronic proctalgia was tested by steroid caudal block 
and by pelvic tender point injection of  a mixture of  Tri-
amcinolone Acetonide and Lidocaine with negative re-
sults[8,11]. Sacral nerve stimulation was also reported to be 
beneficial in an open study involving 27 chronic proct-
algia patients. However, when benefits were assessed by 
intent to treat analysis, pain relief  was reported in less 
than 50% of  subjects[21].
A major drawback in assessing the literature on chron-
ic proctalgia treatment is the huge variation in inclusion 
criteria, outcome criteria, and follow-up intervals. Ad-
ditional limitations are small sample sizes and lack of  an 
appropriate control group. The few quasi-randomized 
studies had control groups that included subjects who 
received more than one treatment and patients not 
responding to a former therapy[7]. To overcome these 
limitations, Chiarioni and coworkers recently reported a 
prospective, randomized controlled trial of  157 chronic 
proctalgia patients to investigate the comparative effec-
tiveness of  the 3 most commonly prescribed treatments: 
biofeedback to teach pelvic floor muscle relaxation, 
EGS, and digital massage of  the levator muscles[2]. A 
physiological assessment including manometry and bal-
loon defecation was carried-out at baseline and at 1-3 mo 
follow-up. In addition, self-reported stool frequency was 
assessed at baseline and at 6-mo follow-up. The primary 
outcome was subjective reporting of  adequate pain re-
lief  by the patient. Secondary outcomes included subjec-
tive pain improvement on an ordinal scale, number of  
days per month with rectal pain, and visual analog scale 
ratings of  pain. According to Rome Ⅱ criteria, proctal-
gia patients were subgrouped into highly likely LAS and 
possible LAS based on the presence or absence of  leva-
tor tenderness at digital rectal exam, and randomization 
to treatment groups was stratified so that each treatment 
group contained a similar number of  patients with a 
highly likely diagnosis of  LAS. 
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At one-month follow-up, biofeedback was signifi-
cantly more effective than EGS and massage by intent-
to-treat analysis, with adequate relief  of  pain reported by 
59.6% vs 32.7% vs 28.3% for biofeedback, EGS, and mas-
sage, respectively. Benefits were maintained throughout 
follow-up (12 mo) and no side effects were reported with 
any treatment. When results were further investigated in 
subgroups of  patients, no treatment was effective in pos-
sible LAS patients (Rome Ⅲ unspecified functional ano-
rectal pain). However, among patients with highly likely 
LAS (Rome Ⅲ levator ani syndrome) adequate relief  
was reported by 87% for biofeedback, 45% for EGS and 
22% for massage at 1 mo follow-up. Improvements were 
maintained for the whole follow-up. The superiority of  
biofeedback was supported by all the secondary outcome 
measures including number of  days per month with pain, 
which decreased from 14.7 per month to 3.3 per month 
for biofeedback, 8.9 for EGS, and 13.3 for massage[2]. 
Physiological measurements revealed that the mecha-
nism for achieving adequate pain relief  was an improve-
ment in pelvic floor function from being unable to relax 
anal canal pressures on straining to being able to do so 
and/or an improvement on the balloon evacuation test 
from being unable to pass a 50 mL balloon to being 
able to do so[2]. This interpretation of  the mechanism 
of  action was confirmed by a post-hoc analysis show-
ing that 94.2% of  those who improved pelvic floor 
dysfunction on one or both of  these measures reported 
adequate pain relief, while only 13.6% of  those who 
did not improve pelvic floor function reported positive 
therapy outcome regardless of  the treatment provided. 
In addition, stool frequency increased from baseline to 
post-treatment in responders, even in the absence of  
a former complaint of  constipation. This study led us 
to conclude that biofeedback is an effective treatment 
for LAS, and EGS is somewhat effective. However, the 
minority of  proctalgia patients affected by unspecified 
functional anorectal pain are still left without a satisfac-
tory treatment option. In this regard, depression and 
anxiety are both frequently reported in non-responsive 
proctalgia patients[6,10]. Brain processing of  pain may be 
altered in functional gastrointestinal disorders, but data 
in proctalgia patients are lacking[22]. In addition, no trial 
has actually evaluated the effect of  either psychotherapy 
intervention or psychotropic drugs in proctalgia patients. 
Finally, there is no evidence that surgery can help these 
severely disabled patients. Invasive interventions should 
be avoided in the absence of  a clearer etiologic under-
standing of  non-responsive proctalgia patients[3].
COCCYGODYNIA
Coccygodynia is defined as pain arising in or around the 
coccyx, usually triggered by prolonged sitting on hard 
surfaces[23]. The pain is considered chronic when it lasts 
more than two months and it is commonly reported 
after repetitive trauma or childbirth[23,24]. Coccygodynia 
may also be of  idiopathic origin or secondary to lumbar 
disc degeneration[23-25]. It is also rarely reported as a com-
plication of  epidural injection of  anesthetic or of  vari-
ous rectal and spine surgery[25]. 
Pathophysiology
It is up to five times more common in women than in men, 
and obesity seems to be a predisposing factor due to the 
associated pelvic rotation[23-25]. The female pelvic anatomy 
may also predispose to coccygodynia by leaving the coc-
cyx more exposed to traumatic injury. The exact etiologic 
mechanism/s associated with coccygodynia are still ob-
scure. Chronic spasm of  the pelvic floor exerting a pain-
ful tension on a stiff  coccyx has been traditionally con-
sidered a relevant etiologic factor, with accidental trauma 
acting as a trigger[23-25]. However, instability of  the coccyx 
potentially correlated with symptom severity was then 
discovered in a high percentage of  patients by dedicated 
X-Ray examination[26]. In addition, it is unclear whether 
pre-existing spine alterations play a role by predisposing 
patients to develop post-traumatic coccygodynia[26,27]. In-
flammation of  structures (i.e., bursitis) in close proximity 
to the spine has also been described as a causative factor 
in a minority of  patients complaining of  coccygodynia[27]. 
Depression and anxiety disorder have been reported to 
amplify coccygeal pain symptoms[23]. Some authors do 
not diagnose coccygodynia when there is an ongoing 
medicolegal litigation, even if  it occurs following a trau-
matic injury[24,25]. 
Clinical presentation
Pain in the coccyx and in close anatomical regions (sa-
crum, perineum, anorectum) is the main reported symp-
tom[23]. Epidemiologic data on coccygodynia in the gener-
al population are lacking, but coccygodynia is considered 
to be a rare disorder. Retrospective data suggest that coc-
cygodynia accounts for less than 1% of  all reported cases 
of  lower back pain[24,25]. Diagnosis of  coccygodynia relies 
heavily on history and clinical exam. Questioning the 
patient about previous trauma to the coccyx or childbirth 
trauma is a must, since according to Salvati the absence 
of  a previous trauma makes the diagnosis unlikely[9]. In 
addition, patients should report worsening of  pain by 
prolonged sitting, bending, lifting or having a restricted 
poor posture for long intervals[23-25]. Some patients may 
report that standing from a sitting position triggers the 
pain[23].
Diagnostic assessment
Reproducing the usual pain by pressure or manipulation 
of  the coccyx is key to diagnosis[23]. Patients may also 
report mild tenderness on puborectalis posterior traction 
on digital rectal examination and a differential diagnosis 
of  chronic proctalgia needs to be entertained[9,28]. How-
ever, this maneuver should never be able to provoke the 
usual pain. Abnormal movement of  the coccyx on pal-
pation is an additional sign to confirm the clinical suspi-
cion of  coccygodynia[25]. Dynamic X-Ray investigation 
may support the clinical diagnosis. The standard lateral 
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X-Ray investigation of  the coccyx in the standing posi-
tion should be supplemented with a second film taken 
while the patient is sitting on a hard surface possibly in 
a posture worsening the pain[26]. More than 50% of  pa-
tients would show features of  coccyx instability (either 
exaggerated flexion or luxation) that seem to correlate 
with pain severity and previous traumatic events. An 
additional 15% of  coccygodynia patients would show 
features of  an abnormal bone spur at the end of  the 
tailbone (so called spicule)[26]. Spine magnetic resonance 
imaging (MRI) could be performed to exclude tumors or 
disc disease, but do not seem to add significantly to the 
diagnosis in coccygodynia[25]. 
Treatment
The initial treatment of  coccygodynia is focused on 
avoiding potentially offending factors and includes sitting 
on a donut-shaped pillow or a gel cushion to reduce pres-
sure, posture ameliorating interventions, sitz bath and 
on demand nonsteroidal anti-inflammatory drugs[23,24]. 
This treatment is commonly applied for 6-8 wk. No con-
trolled study has investigated the therapeutic outcome of  
these simple measures. When initial treatment fails most 
authors recommend adding digital manipulation of  the 
coccygeal ligaments as well as intrarectal manipulation 
of  the pelvic floor muscles. Various massage and ma-
nipulation techniques have been described in open stud-
ies to decrease coccygeal pain in up to 85% of  patients, 
particularly when combined with local steroid injection 
or physiotherapy[29]. A recent prospective, randomized, 
controlled study aimed to compare intrarectal pelvic floor 
muscles manipulation (3 sessions) vs placebo physiother-
apy (sacral short wave magnetic field applied at marginal 
power) in 102 chronic coccygodynia patients[30]. Primary 
outcome was subjective decrement of  more than 50% in 
pain intensity on a visual analog scale score at follow-up 
intervals of  1-6 mo. At 1 mo follow-up, 22% of  patients 
in the manipulation group reported a significant pain 
decrement compared to only 12% of  patients in the pla-
cebo group. Benefits persisted throughout follow-up in 
both groups. Manipulation was more effective in recent 
onset coccygodynia of  post-traumatic origin not associ-
ated with instability of  the coccyx. Psychosocial factors 
seemed to predict a poorer treatment outcome. The au-
thors concluded that intrarectal manipulation is at least 
mildly effective in chronic coccygodynia and suggested 
either to increase the number of  therapeutic sessions or 
to add local steroid injection to improve outcome. How-
ever, no randomized study has actually evaluated both 
treatment options for coccygodynia. In selected patients 
with severe and unresponsive coccygodynia, surgery may 
be considered[31]. 
A recent review on surgical treatment of  coccygo-
dynia reported on 24 studies, but 22 of  them were ret-
rospective case series[32]. Surgery was a treatment option 
in a minority of  patients (approximately 19%), but mean 
satisfaction rate for pain relief  was high (over 80% of  
treated patients). Some series reported a satisfactory out-
come of  just 54% which was attributed to patient selec-
tion bias. Mean overall complication rate was 10.9% with 
wound infection being the most commonly reported 
complication. Surgeon expertise seemed to play a role 
since the smallest series reported the highest procedure-
related complication rates (up to 50%). The type of  
surgery chosen was either total or partial removal of  
the coccyx and this did not seem to influence outcome. 
However, the worst outcomes were reported in patients 




Pudendal neuralgia is a chronic pain in the perineal area 
secondary to entrapment and injury to the pudendal 
nerve in its musculo-osteo-aponeurotic tunnel between 
the sacrotuberal and sacrospinal ligaments, in the ab-
sence of  organic diseases that may explain this symp-
tom[23]. Pudendal neuralgia has been rarely described as 
secondary to herpetic neuropathy, stretch neuropathy, 
and post-radiotherapy neuropathy, but pudendal nerve 
entrapment is by far the most common etiology[33,34]. Pu-
dendal neuralgia is also called Alcock’s canal syndrome, 
or pudendal canal syndrome[23]. 
Clinical presentation
It is commonly described as a superficial pain, burn-
ing sensation, numbness, or paresthesia in the gluteal, 
perineal, and/or genital areas[23]. It may be homolateral 
or bilateral, radiate to the pelvis and the thighs, and be 
associated with deep pelvic discomfort[33,34]. Pain may be 
worsened by sexual intercourse and initially reported as 
sciatic pain[33,34]. The epidemiology of  pudendal neuralgia 
in the general population is unknown. The diagnosis is 
rarely considered except in highly focused Pelvic Floor 
Units or in specialized Urogynecologist practices. It is 
usually considered to be a rare entity, but it may be over-
diagnosed due to the functional comorbidities associated 
with pudendal nerve dysfunction[33,34]. Recently, a multi-
disciplinary Committee reported that pudendal neuralgia 
may be simply diagnosed by default in the presence of  
pelvic, perineal, and buttock pain without evidence of  
organic disease at diagnostic workup[35]. Particularly con-
troversial is its association with rectal pain, the presence 
of  which requires differential diagnosis with chronic 
proctalgia[23]. 
Diagnostic evaluation
Clinical neurophysiology has improved our knowledge 
of  this disorder, but a definitive diagnostic test is still not 
available. As in many neuropathic pain syndromes, the 
diagnosis of  pudendal neuralgia remains primarily clini-
cal and should be reviewed in the light of  the course of  
the disease. In 2006, a multidisciplinary working party 
on pudendal neuralgia held in Nantes, France, concluded 
that only the operative finding of  nerve entrapment 
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and post-operative pain relief  can formally confirm the 
diagnosis, provided the placebo effect of  surgery is ex-
cluded[35]. However, this panel of  experts identified four 
domains of  diagnostic criteria for pudendal neuralgia: (A) 
essential criteria, (B) complementary diagnostic criteria, 
(C) exclusion criteria, (D) associated signs not excluding 
the diagnosis. Essential criteria are particularly relevant 
and will be discussed in detail. (1) Pain should be limited 
to the innervation territory of  the pudendal nerve. This 
excludes any pain that is limited to the coccygeal, pelvic 
or gluteal areas; (2) Pain is predominantly experienced 
while sitting, in accordance with the nerve compression 
etiology hypothesis. In long-standing pudendal neuralgia, 
pain may become continuous, but it is still worsened by 
the sitting position; (3) The pain rarely awakens the pa-
tient at night; (4) On clinical examination, no objective 
sensory impairment can be found even in the presence 
of  paresthesia. The presence of  a sensory defect should 
prompt investigations to exclude diseases of  the sacral 
nerve roots and the cauda equina; and (5) Pain should be 
relieved by anesthetic infiltration of  the pudendal nerve. 
This is an essential criterion, but it lacks specificity as 
pain related to any perineal disease may be relieved by 
pudendal nerve block. Moreover, a negative block does 
not exclude the diagnosis of  pudendal neuralgia because 
it may have been performed inadequately (e.g., too dis-
tally). The complementary diagnostic criteria include the 
sensation of  a rectal foreign body and the worsening of  
pain during defecation, both of  which should prompt 
the physician to entertain the differential diagnosis of  
chronic proctalgia. Exclusion criteria for pudendal neu-
ralgia are pain in a territory unrelated to the pudendal 
nerve, symptomatic pruritus instead of  paresthesia, 
exclusively paroxysmal pain, and imaging abnormalities 
that could explain the symptom[35]. 
Treatment
Pudendal neuralgia is treated by pudendal nerve block, 
which is both diagnostic and therapeutic. However, data 
on the long-term benefits of  pudendal nerve block are 
lacking[35]. In addition, only the operative demonstration 
of  nerve entrapment and post-operative pain relief  can 
formally confirm the diagnosis of  pudendal neuralgia 
secondary to it, except for a potential placebo effect of  
surgery[35].
CHRONIC PELVIC PAIN IN WOMEN
Chronic pelvic pain (CPP), which is diagnosed only in 
women, is commonly defined as noncyclic, nonmalignant 
pain in any organs related to the pelvis, in the absence 
of  pregnancy and inflammatory bowel disease, that has 
lasted for at least six months[36]. Pain occurring exclusive-
ly in association with menstruation (dysmenorrhea) and 
sexual intercourse (dyspareunia) are generally not consid-
ered to be CPP, but general agreement is lacking. Other 
definitions include a pain severity sufficient to cause 
functional disability or to require medical care[36]. Since 
the definition of  CPP varies, it is difficult to ascertain 
its exact prevalence. However, the prevalence of  CPP in 
the general population assessed by mail questionnaires 
among women aged 18-50 has been reported to be as 
high as 15% in the United States and 24% in the United 
Kingdom[37,38]. CPP has been estimated to account for 
10% of  all outpatient referrals to gynecologists and 40% 
of  diagnostic laparoscopies, so it constitutes a significant 
economic burden[39,40]. No organic disease is found on 
laparoscopy in at least a third of  women with CPP[40]. 
In the community, 32% of  patients who consult for this 
symptom report high rates of  anxiety and quality of  life 
impairment as measured by the SF-36[37,38]. Consulting 
behavior is directly influenced by the severity of  pain[39]. 
Pathophysiology
The etiology of  CPP is considered to be complex and 
multifactorial[36,40]. Some gynecological diseases such as 
endometriosis, pelvic inflammatory disease, and intersti-
tial cystitis may cause CPP, but gastrointestinal comor-
bidities are also reported in up to 1/3 of  CPP patients in 
primary care[38,40]. A psychosomatic component of  pain 
has also been hypothesized[36,40]. The common associa-
tion of  CPP with irritable bowel syndrome has led some 
to question whether these two diseases are actually a 
single clinical entity that is diagnosed differently accord-
ing to the specialist consulted[41]. The etiology of  CPP is 
poorly understood. 
Diagnostic assessment
Initial evaluation should include a history and physi-
cal examination to narrow the differential diagnosis[40]. 
When this examination does not identify another expla-
nation for the pain, limited laboratory testing and trans-
vaginal ultrasound scanning is often employed to rule out 
organic disease and reassure the patient[40]. The labora-
tory workup should include: complete blood count, beta 
human chorionic gonadotropin level, erythrocyte sedi-
mentation rate, vaginal swabs for Chlamydia and Gonor-
rhea, and urinalysis with urine and culture[40]. Additional 
magnetic resonance imaging should be considered when 
in doubt for organic disease and diagnostic laparoscopy 
may be eventually performed in selected cases[40]. A tense 
pelvic floor is often reported during vaginal examination 
in CPP and spasm of  the pelvic floor muscles is consid-
ered a relevant etiologic factor[36]. In addition, up to 60% 
of  patients may report symptoms of  either voiding dys-
function or dyschezia[42]. 
Treatment
Physiotherapy to relax the pelvic floor is often prescribed 
as first-line treatment for CPP, but randomized, con-
trolled trials to confirm its effectiveness are lacking. Vag-
inal electrical stimulation was retrospectively reported to 
decrease pain in 52% of  66 chronic pelvic pain patients 
when coexistent levator ani spasm was also diagnosed by 
clinical exam[43]. Benefits were generally sustained during 
a 30-wk follow-up. Nonetheless, few studies have evalu-
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ated pelvic floor function in women with CPP. Abbott 
and coworkers reported pelvic floor myalgia in 68 out 
of  118 patients referred for long-standing, unresponsive 
CPP[44]. They diagnosed pelvic floor myalgia based on 
objective evidence of  contracted, painful pelvic muscles 
on palpation and elevated resting intraluminal pressures 
as measured by vaginal manometry. This study was a 
double blind, placebo controlled trial to test the efficacy 
of  BoTox A in patients who had CPP with pelvic floor 
spasm. BoTox injection was associated with a significant 
reduction in vaginal resting pressure compared to pla-
cebo, but pain was only partially relieved and was not 
significantly different between BoTox and placebo. The 
authors concluded that pelvic floor spasm can cause 
CPP and that improvement in some symptoms occurs 
following reductions in muscle spasm[44]. In open studies, 
a number of  treatment modalities have been reported 
to be effective for decreasing symptoms in CPP. These 
options include either oral or intramuscular hormone 
therapy, levator ani trigger point steroid injections, and 
sacral neuromodulation[36,40,42,45]. Most studies are open, 
retrospective, single center experiences with poor gener-
alizability of  treatment outcome. 
Tricyclic antidepressants and Sertraline seem to work 
no better than placebo in CPP[40]. Surgery should be lim-
ited to patients with an organic cause for pelvic pain[36,40]. 
In non-responsive, severely disabled patients a multidis-
ciplinary approach is advocated to fit with a biopsycho-
social model of  pain[40].
CONCLUSION
Chronic anorectal and pelvic pain syndromes receive little 
research attention despite the fact that they are prevalent, 
often disabling pain syndromes which are associated with 
significant health care costs and quality of  life impact. 
Their frequency in the general population may be as high 
as 24% for chronic pelvic pain in women and 6.6% for 
chronic proctalgia. It is common for these patients to be 
referred to multiple specialists. Etiology is poorly defined, 
but chronic tension (spasm) in the striated muscles of  
the pelvic floor is often considered to be the pathophysi-
ological mechanism for most of  them. A recent random-
ized, controlled trial provided evidence that dyssynergic 
defecation (i.e., paradoxical contraction or failure to relax 
the pelvic floor muscles when straining to defecate) is the 
primary cause of  pain for the majority of  patients with 
chronic proctalgia, even for patients who do not com-
plain of  constipation. Biofeedback to treat dyssynergic 
defecation was an effective treatment for the subset of  
patients with chronic proctalgia who reported tender-
ness when traction was applied to the levator ani muscles 
during digital rectal exam (a sign of  excessive tension in 
these muscles). This finding should prompt researchers 
to look for features of  dyssynergic defecation in other 
pelvic pain syndromes and to try a similar treatment. A 
multidisciplinary and tailored approach to treat anorectal 
and pelvic pain patients without pelvic floor dysfunction 
is strongly suggested.
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